Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma

Cancer Research

Volumn 62, Issue 24, 2002, Pages 7181-7185

  Wotton, Sandy ^a   Stewart, Monica ^a   Blyth, Karen ^a   Vaillant, Francois ^a   Kilbey, Anna ^a   Neil, James C ^a   Cameron, Ewan R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; DNA; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; GENE INSERTION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MULTIGENE FAMILY; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUNX1 GENE; T CELL LYMPHOMA; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE DOSAGE; GENE EXPRESSION; GENES, DOMINANT; GENES, MYC; GENES, TUMOR SUPPRESSOR; LEUKEMIA VIRUS, MURINE; LYMPHOMA, T-CELL; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; ONCOGENES; PROTO-ONCOGENE PROTEINS; PROVIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 0037115419     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Song, W-J., Sullivan, M., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., Loh, M., Felix, C., Roy, D-C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A. M., Speck, N. A., Bushweller, J. H., Li, F. P., Gardiner, K., Poncz, M., Maris, J. M., and Gilliland, D. G. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet., 23: 166-175, 1999.
2. Osata, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., and Ito, Y. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukeamias. Blood, 93: 1817-1824, 1999.
3. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84: 321-330, 1996.
4. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., and Speck, N. A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA, 93: 3444-3449, 1996.
5. Downing, J. R., Higuchi, M., Lenny, N., and Yeoh, A. Alterations of the AML1 transcription factor in human leukaemia. Semin. Cell Dev. Biol., 11: 347-360, 2000.
6. Stewart, M., Terry, A., O'Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D., and Neil, J. C. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): Evidence for a new myc collaborating gene. Proc. Natl. Acad. Sci. USA, 94: 8646-8651, 1997.
7. Vaillant, F., Blyth, K., Terry, A., Bell, M., Cameron, E. R., Neil, J., and Stewart, M. A full length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with MYC. Oncogene, 18: 7124-7134, 1999.
8. Stewart, M., Mackay, N., Cameron, E. R., and Neil, J. C. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Am12 gene. J. Virol., 76: 4364-4369, 2002.
9. Li, J., Shen, H., Himmel, K. L., Dupuy, A. J., Largaespada, D., Nakamura, T., Shaughnessy, J. D., Jenkins, N. A., and Copeland, N. G. Leukaemia disease genes: Large scale cloning and pathway predictions. Nat. Genet., 23: 348-353, 1999.
10. Chan, H., Krstic-Demonacos, M., Smith, L., Demonacos, C., and La Thangue, N. Acetylation control of the retinoblstoma tumour-supressor protein. Nat. Cell Biol., 3: 667-674, 2001.
11. Cullen, B., Lomedico, P., and Ju, G. Transcriptional interference in avian retrovirus -implications for the promoter insertion model of leukaemogenesis. Nature (Lond.), 307: 241-245, 1984.
12. Bae, S. C., Yamaguchi-Iwai, Y., Ogawa, E., Maruyama, M., Inuzuka, M., Kagoshima, H., Shigesada, K., Satake, M., and Ito, Y. Isolation of PEBP2 α B cDNA representing the mouse homolog of human acute myeloid leukemia gene AML1. Oncogene, 8: 809-814, 1993.
13. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., and Ito, Y. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA, 90: 6859-6863, 1993.
14. Bae, S-C., Ogawa, E., Murayama, M., Oka, H., Satake, M., Shigesada, K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., and Ito, Y. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol., 14: 3242-3252, 1994.
15. Allen, J., and Berns, A. Complementation tagging of cooperating oncogenes in knockout mice. Semin. Cancer Biol, 7: 299-306, 1996.
16. Michaud, J., Wu, F., Osato, M., Cottles, G. M., Yanagida, M., Asou, N., Shigesada, K., Ito, Y., Benson, K. F., Raskind, W. H., Rossier, C., Antonarakis, S. E., Israels, S., McNicol, A., Weiss, H., Horwitz, M., and Scott, H. S. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: Implications for mechanisms of pathogenesis. Blood, 99: 1364-1372, 2002.
17. Telfer, J. C., and Rothenberg, E. Expression and function of a stem cell promoter for the murine CBFA2 gene: Distinct roles and regulation in natural killer and T cell development. Dev. Biol., 229: 363-382, 2001.
18. Levanon, D., Glusman, G., Bangsow, T., Ben-Asher, E., Male, D. A., Avidan, N., Bangsow, C., Hattori, M., Taylor, T. D., Taudien, S., Blechschmidt, K., Shimizu, N., Rosenthal, A., Sakaki, Y., Lancet, D., and Groner, Y. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene (Amst.), 262: 23-33, 2001.
19. Satake, M., Nomura, S., Yamagachi-Iwai, Y., Takahama, Y., Hashimoto, Y., Niki, M., Kitamura, Y., and Ito, Y. Expression of the runt domain-encoding PEBP2a genes in T cells during thymic development. Mol. Cell. Biol., 15: 1662-1670, 1995.
20. Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Yazaki, Y., Shibata, Y., and Hirai, H. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms. Leukemia (Baltimore), 11(Suppl 3): 299-302, 1997.
21. Kurokawa, M., Tanaka, T., Tanaka, K., Ogawa, S., Mitani, K., Yazaki, Y., and Hirai, H. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies. Oncogene, 12: 883-892, 1996.
22. Cao, W., Britos-Bray, M., Claxton, D. F., Kelley, C. A., Speck, N. A., Liu, P. P., and Friedman, A. D. CBF β-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells. Oncogene, 15: 1315-1327, 1997.
23. Pozner, A., Goldenberg, D., Negreanu, V., Le, S. Y., Elroy-Stein, O., Levanon, D., and Groner, Y. Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms. Mol. Cell Biol., 20: 2297-2307, 2000.
24. Niini, T., Kanerva, J., Vettenranta, K., Saarinen-Pihkala, U. M., and Knuutila, S. AML1 gene amplification: A novel finding in childhood acute lymphoblastic leukemia. Haematologica, 85: 362-366, 2000.
25. Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C. J., van Deursen, J. M., Harada, H., and Downing, J. R. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood, 91: 3134-3143, 1998.
26. Li, Q. L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K., Chi, X. Z., Lee, K. Y., Nomura, S., Lee, C. W., Han, S. B., Kim, H. M., Kim, W. J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, A., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S. C., and Ito, Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 109: 113-124, 2002.